Wolverine Trading
LXRX icon

Wolverine Trading’s Lexicon Pharmaceuticals LXRX Stock Holding History

Wolverine Trading’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$29.5K Buy
+21,191
New +$24.1K ﹤0.01% 5501
2024
Q4 		– Sell
-11,192
Closed -$13.5K – 5625
2024
Q3 		$17.9K Buy
+11,192
New +$19.9K ﹤0.01% 4654
2024
Q1 		– Sell
-14,018
Closed -$30.1K – 4938
2023
Q4 		$21.4K Sell
14,018
-3,396
-20% -$4.04K ﹤0.01% 4365
2023
Q3 		$19K Sell
17,414
-3,275
-16% -$5.75K ﹤0.01% 4324
2023
Q2 		$44.9K Buy
+20,689
New +$54.9K ﹤0.01% 3973
2022
Q3 		– Sell
-22,169
Closed -$50K – 5020
2022
Q2 		$50K Buy
+22,169
New +$42.3K ﹤0.01% 4064
2021
Q4 		– Sell
-13,652
Closed -$66.3K – 6441
2021
Q3 		$67K Sell
13,652
-25
-0.2% -$103 ﹤0.01% 5946
2021
Q2 		$68K Buy
+13,677
New +$65.9K ﹤0.01% 5542
2021
Q1 		– Sell
-12,444
Closed -$86.2K – 6182
2020
Q4 		$41K Buy
+12,444
New +$23.7K ﹤0.01% 4639
2020
Q3 		– Sell
-11,203
Closed -$19.9K – 4887
2020
Q2 		$22K Buy
+11,203
New +$22K ﹤0.01% 4427
2020
Q1 		– Sell
-20,161
Closed -$83K – 4990
2019
Q4 		$83K Sell
20,161
-15,102
-43% -$58.1K ﹤0.01% 4338
2019
Q3 		$121K Buy
+35,263
New +$109K ﹤0.01% 3794
2019
Q2 		– Sell
-36,282
Closed -$217K – 4838
2019
Q1 		$202K Buy
+36,282
New +$220K ﹤0.01% 3816

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wolverine Trading's LXRX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Lexicon Pharmaceuticals (LXRX) in Q3 2025: 21,191 shares worth $29.5K. The stake represents ﹤0.01% of the portfolio and ranks #5501 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in LXRX as recently as Q3 2024.

Wolverine Trading first reported a position in LXRX in Q1 2019 and has held it in 13 quarters since. The position peaked at $202K in Q1 2019. 123 funds tracked by Wall St. Rank hold LXRX as of Q3 2025.

  • Wolverine Trading held 21,191 shares of Lexicon Pharmaceuticals worth $29.5K as of Q3 2025.
  • Lexicon Pharmaceuticals was a new Wolverine Trading position in Q3 2025.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5501 holding.
  • Wolverine Trading first reported a position in Lexicon Pharmaceuticals in Q1 2019 and has held it in 13 quarters since.
  • Wolverine Trading's Lexicon Pharmaceuticals position peaked at $202K in Q1 2019.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.